Orgenesis Enters Into R&D Agreement With The Fraunhofer IGB DailyFinance "We are very excited to support Orgenesis in their development of a very promising new therapy for diabetes that overcomes the problem of donor shortage and removes the risk of transplant rejection. This project fits exactly into our strategy to ... |
